metricas
covid
Gastroenterología y Hepatología (English Edition) Budesonide in the first line treatment of patients with autoimmune hepatitis
Journal Information

Statistics

Follow this link to access the full text of the article

Review
Budesonide in the first line treatment of patients with autoimmune hepatitis
Budesonida en primera línea de tratamiento de pacientes con hepatitis autoinmune
Ignasi Olivasa, Marina Cobrerosb, María-Carlota Londoñoa, Álvaro Díaz-Gonzálezb,
Corresponding author
alvaro.diaz@scsalud.es

Corresponding author.
a Liver Unit, Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERehd, Universitat de Barcelona, Barcelona, Spain
b Digestive Diseases Department, Marqués de Valdecilla University Hospital, Instituto de investigación sanitaria Valdecilla (IDIVAL), Santander, Spain
Read
1338
Times
was read the article
439
Total PDF
899
Total HTML
Share statistics
Article information
ISSN: 24443824
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 75 24 99
2025 11 295 184 479
2025 10 83 58 141
2025 9 45 91 136
2025 8 42 16 58
2025 7 47 10 57
2025 6 34 3 37
2025 5 29 8 37
2025 4 37 2 39
2025 3 27 8 35
2025 2 28 4 32
2025 1 42 1 43
2024 12 14 6 20
2024 11 32 3 35
2024 10 9 5 14
2024 9 10 1 11
2024 8 13 4 17
2024 5 1 0 1
2024 3 1 0 1
2024 2 1 0 1
2024 1 1 0 1
2023 12 4 2 6
2023 11 2 0 2
2023 10 3 0 3
2023 9 1 0 1
2023 7 3 0 3
2023 6 4 0 4
2023 5 6 5 11
2023 3 3 2 5
2022 12 2 0 2
2022 11 2 2 4
2022 10 1 0 1
2022 9 2 0 2
Show all

Follow this link to access the full text of the article